LENSAR, Inc. (LNSR) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Orlando, FL, 미국. 현재 CEO는 Nicholas T. Curtis.
LNSR 을(를) 보유 IPO 날짜 2020-10-02, 140 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $73.06M.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
